Conception

About Conception

Conception.bio is a pioneering biotech startup focused on revolutionizing fertility treatments. The company operates in the fertility and reproductive health market, aiming to provide innovative solutions for individuals and couples facing infertility challenges. Conception.bio's primary clientele includes women looking to extend their fertility window, couples struggling with infertility, and same-sex male couples desiring biological children.

The core of Conception.bio's business lies in its cutting-edge research and development. The company has developed a unique process to generate viable egg cells from blood samples. This involves creating induced pluripotent stem cells (iPSCs) from blood and guiding these cells through the stages necessary to become mature egg cells. This groundbreaking technology has the potential to allow women to have children later in life, offer new hope to infertile couples, and enable genetic screening of embryos to prevent hereditary diseases.

Conception.bio operates on a B2C (business-to-consumer) model, directly serving individuals and couples seeking fertility solutions. The company generates revenue through the sale of its fertility treatments and related services. By offering a novel approach to egg cell development, Conception.bio positions itself as a leader in the fertility treatment market, which is projected to grow significantly in the coming years.

The company prides itself on its collaborative and resource-rich research environment. The team comprises highly skilled scientists and researchers dedicated to achieving the shared goal of advancing fertility science. This collective effort ensures that Conception.bio remains at the forefront of fertility innovation.

In summary, Conception.bio is a biotech startup that leverages advanced stem cell technology to address infertility issues, serving women, infertile couples, and same-sex male couples. The company operates in the fertility and reproductive health market, generating revenue through direct consumer sales of its innovative treatments.